Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study

Published:2012-01-14 Issue:6 Volume:91 Page:931-939
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Rigacci Luigi, ,Puccini Bendetta,Dodero Anna,Iacopino Pasquale,Castagna Luca,Bramanti Stefania,Ciceri Fabio,Fanin Renato,Rambaldi Alessandro,Falda Michele,Milone Giuseppe,Guidi Stefano,Martelli Massimo Fabrizio,Mazza Patrizio,Oneto Rosi,Bosi Alberto

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-011-1395-9.pdf

Reference47 articles.

1. Philip T, Chauvin F, Armitage J, Bron D, Hagenbeek A, Biron P, Spitzer G, Velasquez W, Weisenburger DD, Fernandez-Ranada J, Somers R, Rizzoli V, Harousseau JL, Sotto JJ, Cahn JY, Gullhot F, Biggs J, Sonneveld P, Misset JL, Manna A, Jagannath S, Guglielmi C, Chevreau C, Delmer A, Santini G, Coiffier B (1991) Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 77(7):1587–1592

2. Vitolo U, Chiappella A, Angelucci E, Rossi G, Liberati AM, Cabras MG, Botto B, Ciccone G, Gaidano G, Falchi L, Freilone R, Novero D, Orsucci L, Pavone V, Pogliani E, Rota-Scalabrini D, Salvi F, Tonso A, Tucci A, Levis A (2009) Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Hematologica 94(9):1250–1258

3. Haioun C, Mounier N, Emile JF, Ranta D, Coiffier B, Tilly H, Recher C, Fermé C, Gabarre J, Herbrecht R, Morchhauser F, Gisselbrecht C (2009) Rituximab versus observation after high dose consolidative first-line chemotherapy with autologous stem cell transplantation in patients with poor risk diffuse large-B cell lymphoma. Ann Oncol 20(12):1985–1992

4. Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J, Prappier B, Schmit-Pokorny K, Weisenburger DD, Armitage JO (1992) Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 80(8):2142–2148, 15

5. Vanderbenghe E, Pearce R, Taghipour G, Fouillard L, Goldstone AH (1997) Role of a second transplant in the management of poor prognosis lymphomas: a report from the European Blood and Marrow Registry. J Clin Oncol 15:1595–1600

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature;Annals of Hematology;2024-03-02

2. Allogeneic hematopoietic stem cell transplantation for B‐cell lymphoma in Taiwan;Cancer Medicine;2023-11-28

3. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma;Transplantation and Cellular Therapy;2023-09

4. Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy;Current Oncology Reports;2023-03-28

5. Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma;Transplantation and Cellular Therapy;2023-02